首页
产品目录
分子砌块
按官能团
芳基卤化物
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
产品编号 :
Cas No. :
| 包装规格 |
纯度 |
目录价 |
会员专享价 |
库存 |
数量 |
| 1g |
95% |
|
|
询价 |
|
| 5g |
95% |
|
|
询价 |
|
| 10g |
95% |
|
|
询价 |
|
| 25g |
95% |
|
|
询价 |
|
| 100g |
95% |
|
|
询价 |
|
| 500g |
95% |
|
|
询价 |
|
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No. |
853029-57-9 |
英文名称 |
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
别名 |
8-BroMo-7-(2-butyn-a-yl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-1H-purine-2,6-dione;8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquin-azolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dion;8-BroMo-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione;1H-Purine-2,6-dione,8-broMo-7-(2-butynyl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-;Linagliptin interMediate F;1-[(4-Methylquinazolin-2-yl)Methyl]-3-Methyl-7-(2-butin-1-yl)-8-broMoxanthine;1H-Purine-2,6-dione, 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;Iinagliptin Intermediate3 |
标准英文名 |
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
分子式 |
C20H17BrN6O2 |
分子量 |
453.30
|
精确分子量 |
452.06
|
SMILES |
CC#CCN1C(Br)=NC2=C1C(=O)N(CC1=NC3=CC=CC=C3C(C)=N1)C(=O)N2C |
标准SMILES |
CN1C2N=C(Br)N(CC#CC)C=2C(=O)N(CC2=NC3=CC=CC=C3C(C)=N2)C1=O |
用途 |
This compound is an intermediate used in the preparation of selective dipeptidyl peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes. |
InChIKey |
RCZJXCXNYGHNSR-UHFFFAOYSA-N |